We have isolated a strain of Escherichia coli from chicken caeca which produces two E colicins and colicin M. This strain has seven plasmids, five of which have been transferred to E. cofi K 12. Two E. coli K12 derivatives which produce the two E colicins separately have been tested against seven standard E colicin producing strains which define seven different immunity groups. Our results indicate that these new E colicins define two further immunity groups, E8 and E9.
Transformation procedure. Strain W3110 was made competent for transformation by the method of Mandel & Higa (1970) except that cells were washed with cold 0.1 M-M~CI, prior to the CaCI, wash. After mixing with plasmid DNA from PC252 or PC617, cells were plated on nutrient medium containing a colicin extract of the DNA donor strain. Survivors were screened for the production of the appropriate E colicin.
Preparation of colicin E3 antiserum. A crude colicin E3 extract was prepared from E. coli RJ 179 ColE3-CA38 grown with shaking at 37 "C in LB medium. At an Ass0 of 0.2, mitomycin C (0.5 pg m1-l) was added to 1 1 of culture. After incubation for a further 60 min the cells were harvested by centrifugation at 7000 g for 15 min. The cell pellet was resuspended in 16 ml 10 mM-phosphate buffer pH 7.0 and was sonicated for four periods of 30 s, with 60 s cooling in between, in an ice bath. The sonicated cells were centrifuged at 100OOOg in a Beckman 65 IP: 54.70.40.11
On: Mon, 17 Dec 2018 21:07:59
Two new E colicins 21 1 rotor for 40 min to remove unbroken cells, cell membranes etc. and the supernatant was used as a crude colicin E3 extract to raise antiserum. Two New Zealand White rabbits were injected at multiple sites on the back with 0.5 ml colicin E3 extract (10 mg total protein) mixed with 0.5 ml of Freund's complete adjuvant. At 14 d intervals the rabbits received booster intra-muscular injections of extract, mixed with incomplete Freund's adjuvant. After 42 d blood was removed from the ear vein of both rabbits and allowed to clot. After overnight incubation at 4 "C the serum was pooled and stored in portions at -20 "C.
RESULTS

Properties of strain J
Strain J was isolated from chicken caeca. Colicin E and M activities were shown by the stab/overlayer method. Stab inoculation of strain J gave a large zone (diameter, 12-1 5 mm) with a colicin E-sensitive indicator, a smaller zone with a colicin E-resistant, colicin M-sensitive indicator, and no zone with a colicin E-resistant, colicin M-resistant indicator. Strain J was found to be resistant to tetracycline and to ferment raffinose; raffinose also served as a sole source of carbon. Agarose gel electrophoresis of DNA isolated from strain J showed seven plasmid bands, called pPC 101 -pPC 107 from smallest to largest ( Fig. 1) .
Transfer of colicin E activity to E. coli K12
Strain J was mated with RJ 179, and plated on nalidixic acid to counterselect the donor. One of the few surviving recipient colonies was colicin E + , and agarose gel electrophoresis of DNA isolated from this strain (PC252) showed two plasmid bands, corresponding to pPC101 and pPC104 (data not shown). We assumed that the smaller plasmid was the colicin E plasmid by analogy with other colicin E plasmids, and that the larger was the mobilizing conjugative plasmid. Subsequent transformation of strain W3110 with DNA from this strain yielded an E colicin producing strain which carried pPClOl but not pPC104. We have not yet found a phenotypic character which is conferred by pPC104. 
Transfer of a second colicin E activity from strain J
Conjugation experiments showed that Raf+, the ability to use raffinose as a sole source of carbon, could be transferred from strain J to PC264. This btuB recipient was used to avoid killing by E colicin in the mating mixture. We expected that the Raf+ plasmid might mobilize pPClOl and screened Raf+ progeny for colicin E activity. Of fourteen Raf+ colonies tested, five
were colicin E + . The E colicin of two of them was inactive against PC252 which carries pPClOl, suggesting that these transconjugants also carried pPC101. The E colicin of the other three, however, was active against PC252, which placed it in a different immunity group. Agarose gel electrophoresis of Raf+ colicin E + strains of the latter type, such as PC617, showed two plasmid bands which on the basis of mobility correspond to pPC102 and pPC107. pPC107 was the only plasmid observed on gels with Raf+ colicin Etransconjugants indicating that it is the Raf+ plasmid and pPC102 is the second ColEplasmid. Transformation of W3110 with plasmid DNA from PC617 yielded colicin E+ progeny carrying pPC102, but not pPC107.
Immunity testing with standard ColE strains
Strains PC651 and PC652 which are W3110 transformants carrying pPClOl and pPC102, respectively, were cross-tested against the seven standard colicin E producing strains ( Table 2) . All indicator strains were sensitive to the colicin produced by PC65 1, except the colicin E3 + and colicin E6+ strains which were only partially sensitive. PC651 was sensitive to all E colicins tested. In the case of PC652, its E colicin was active on all other colicin E+ indicators. PC652 was sensitive to all the E colicins except E5, to which it was only partially sensitive.
Tests against colicin tolerant indicators
Chromosomal mutants able to grow in the presence of E colicins but still btuB+ are termed tolerant. TolA and tolD mutants are tolerant to colicins E2 and E3, but not to El ; tolB mutants are tolerant to all three (Bachmann & Low, 1980) . We therefore tested the tolerance of strains A592 (tolA), A593 (tolB), and Gllel (tolD) to all colicin E + strains including pPC651 and pPC652. A592 and Gllel were sensitive to colicin El, but tolerant to all other E colicins. A593 was tolerant to all nine E colicins.
Antigenic relatedness of E colicins
Antiserum prepared to colicin E3 extract was able to protect a sensitive strain against the killing activity of the colicin E3 + strain (Fig. 2) . We found that this antiserum could also protect against the E colicins of PC651 and PC652. It also protected against all the E colicins of the standard strains except colicin El. It did not protect against colicin A.
Other properties of pPCIO7
Transconjugants selected for Raf + and carrying pPC 107 alone gave a colicin zone if they were tonA, lacking the colicin M receptor, but gave no zone if they were tonA+ (Table 3) . This characteristic of colicin M was reported by Fredricq & Smarda (1970) who also found that colicin B activity and colicin M activity were usually determined by the same plasmid. We found that although transconjugants carrying pPC 107 did not produce colicin B, they were completely immune to this colicin. A transmissible Raf+ plasmid was described which also determines hydrogen sulphide production (Orskov & Orskov, 1973) . Neither strain J or E. coli K12 transconjugants carrying pPC107 produce H2S in API 20E tests.
Plasmid pPCIO5 carries tetracycline resistance and also mobilizes strain J ColE plasmids
Selection for tetracycline-resistance (Tc') transconjugants from a mating between strain J and RJ179 (in the presence of trypsin) yielded colicin E-and colicin E + colonies. The colicin E + colonies were of three classes when tested as producers against pPC101-and pPC102carrying indicator strains (Table 4) . Classes 1 and 2 were active on one of the indicators, class 3 was active on both.
Plasmid DNA isolated from representative Tcr transconjugants was elektrophoresed on agarose gels. On the basis of relative mobilities, Tc' colicin Etransconjugants carried pPC 105 Table 4 
. Classes of colicin E producers among tetracycline-resistant transconjugants
The number of colonies is shown in parentheses. alone, class 1 colicin E+ carried pPC105 and pPClOl, class 2 colicin E + carried pPClO5 and pPC102; and class 3 carried pPC105, pPClOl and pPC102 (data not shown). This class was immune to both of the new E colicins. In separate experiments we also found that pPC104 and pPC105 could mobilize pPClOl and pPC102 together, as well as separately.
Stab culture
DISCUSSION
Strain J, a natural isolate of E. coli from chickens has seven plasmids, five of which have been transferred to E. coli K12. pPClOl and pPC102 are ColE plasmids with molecular weights of 6.7 kb and 7.8 kb, respectively (R. James, unpublished) and are mobilized by the transmissible plasmids pPClO4, pPClO5 and pPC107. pPC 107 confers tetracycline resistance and pPC107 confers raffinose utilization as well as colicin M production and immunity to colicins B and M. Our major interest in strain J is the two E colicins it produces. We isolated transformants of E. coli strain W3110 which produce each of the new E colicins separately and tested them against the seven E-colicin type strains provided by the Plasmid Reference Center.
The E colicin of PC65 1 falls into a different immunity group from colicins El, E2, E4, and E7 based on lack of cross-immunity. Both the colicin E3+ and E6+ strains are only partially sensitive to the colicin of PC651, giving smaller, turbid zones compared to the clear zones characteristic of lack of immunity. However, PC651 is fully sensitive to colicins E3 and E6, and the producers of these colicins are sensitive to each other's colicins. There are several possible explanations of these results. One is that colicin E3 immunity (and colicin E6 immunity) can protect to some extent against the colicin of PC651, but not vice versa. Another possibility is that the ColE3 + and the ColE6+ strains carry a separate gene for immunity to the colicin of PC651 in addition to immunity to the colicin they produce.
Males & Stocker (1980) described a strain of E. coli which produces only colicin E7 but is immune to colicin E7 and colicin E2. In this case immunity to colicin E2 was shown to be distinct from E7 immunity and determined by a separate plasmid, C O~E~~, , -K~ 17 (Watson et al., 1981) .
Chak & James (1984) have shown that in the case of the colicin E3+ strain PRC595, immunity to the colicin of PC651 is carried by ColE3-CA38 and is distinct from colicin E3 immunity. ColE3-CA38 has been cloned into pBR322 and this recombinant plasmid confers colicin E3 production and immunity to colicin E3 and the colicin of PC651. The latter immunity was abolished when transposons were inserted in one region of this plasmid without affecting colicin E3 production or immunity. The genetic basis of the immunity of the colicin E6+ strain, PRC608, to the colicin of PC651 is being investigated.
We believe that the colicin of PC651 defines a new immunity group, E8. The colicin will be designated colicin E8-J. The E colicin of PC652, which is active on representatives of all seven standard colicin E + strains tested and PC65 1, defines a further immunity group, E9. The colicin of PC652 will be designated colicin E9-J. The partial immunity of this strain to colicin E5 may be due to a separate E5 immunity gene, and this possibility is being explored. Our limited studies show that E8-J and E9-J are similar to colicins E2 to E7 and different from colicin E l on the basis of antigenicity and their activity on certain colicin-tolerant mutants. Mock & Pugsley (1982) have reported antigenic similarities between colicins E2 to E7 by immunoprecipitation IP: 54.70.40.11
Two new E colicins 215 using antibody to purified colicin E3-CA38. It is not apparent why the E5 immunity of PC652 or the E8 immunity of ColE3-CA38 is only partial whereas the colicin B immunity of pPC107 is complete. Watson et al. (1981) noted that E2 immunity conferred by Col E2,,,-K317 is not completely effective in protecting indicator lawns from colicin E2 by the stab/overlayer method. Pugsley & Reeves (1977) found that some colicin B+ strains were also immune to colicins they did not produce, and occasionally this immunity was partial. Perhaps for certain plasmids immunity without production of the corresponding colicin is at a lower level than when colicin is produced. Strains carrying ColE8-J and ColE9-J will be deposited with the Plasmid Reference Center, Stanford University, Stanford, California 94305, USA.
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